Back to Press


Accelerator SEATTLE

Accelerator, established in 2003, is a biotechnology investment and management company.  Formed by a syndicate of top-tier venture capital investors and a world-class research institution, Accelerator identifies, evaluates, finances, and manages the development of emerging biotechnology opportunities.  Accelerator has built a unique solution that addresses many of the key problems associated with investing in early-stage biotechnology by providing access to venture capital, management, scientific expertise, and facilities.  Over the past 10 years, Accelerator has raised more than $40M in committed capital and has formed and invested in twelve companies.